| |
U133 probe set
|
Gene description
|
Symbol
|
Location
|
GenBank Reference
|
Unigene Reference
|
Chi-square value
|
T-ALL Above/below mean
|
Fold change
|
|
1
|
201137_s_at
|
major histocompatibility complex, class II, DP beta
1
|
HLA-DPB1
|
6p21.3
|
NM_002121.1
|
Hs.814
|
100.0
|
Below
|
24.2
|
|
2
|
202113_s_at
|
sorting nexin 2
|
SNX2
|
5q23
|
AF043453.1
|
Hs.11183
|
100.0
|
Below
|
4.2
|
|
3
|
202114_at
|
sorting nexin 2
|
SNX2
|
5q23
|
NM_003100.1
|
Hs.11183
|
100.0
|
Below
|
4.7
|
|
4
|
203675_at
|
nucleobindin 2
|
NUCB2
|
11p15.1-p14
|
NM_005013.1
|
Hs.3164
|
100.0
|
Above
|
3.7
|
|
5
|
204670_x_at
|
major histocompatibility complex, class II, DR beta
3
|
HLA-DRB3
|
6p21.3
|
NM_002125.1
|
Hs.308026
|
100.0
|
Below
|
15.3
|
|
6
|
205297_s_at
|
CD79B antigen (immunoglobulin-associated beta)
|
CD79B
|
17q23
|
NM_000626.1
|
Hs.89575
|
100.0
|
Below
|
21.8
|
|
7
|
205456_at
|
CD3E antigen, epsilon polypeptide (TiT3 complex)
|
CD3E
|
11q23
|
NM_000733.1
|
Hs.3003
|
100.0
|
Above
|
20.8
|
|
8
|
206398_s_at
|
CD19 antigen
|
CD19
|
16p11.2
|
NM_001770.1
|
Hs.96023
|
100.0
|
Below
|
5693.6
|
|
9
|
208306_x_at
|
major histocompatibility complex, class II, DR beta
4
|
HLA-DRB4
|
6p21.3
|
NM_021983.2
|
Hs.318720
|
100.0
|
Below
|
9.8
|
|
10
|
208894_at
|
major histocompatibility complex, class II, DR alpha
|
HLA-DRA
|
6p21.3
|
M60334.1
|
Hs.76807
|
100.0
|
Below
|
27.5
|
|
11
|
209312_x_at
|
major histocompatibility complex, class II, DR beta
1
|
HLA-DRB1
|
6p21.3
|
U65585.1
|
Hs.375570
|
100.0
|
Below
|
14.6
|
|
12
|
209619_at
|
CD74 antigen (invariant polypeptide of major histocompatibility
complex, class II antigen-associated)
|
CD74
|
5q32
|
K01144.1
|
Hs.84298
|
100.0
|
Below
|
18.9
|
|
13
|
210116_at
|
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome)
|
SH2D1A
|
Xq25-q26
|
AF072930.1
|
Hs.151544
|
100.0
|
Above
|
159.0
|
|
14
|
210982_s_at
|
major histocompatibility complex, class II, DR alpha
|
HLA-DRA
|
6p21.3
|
M60333.1
|
Hs.76807
|
100.0
|
Below
|
32.5
|
|
15
|
211990_at
|
major histocompatibility complex, class II, DP alpha
1
|
HLA-DPA1
|
6p21.3
|
M27487.1
|
Hs.914
|
100.0
|
Below
|
29.4
|
|
16
|
211991_s_at
|
major histocompatibility complex, class II, DP alpha
1
|
HLA-DPA1
|
6p21.3
|
M27487.1
|
Hs.914
|
100.0
|
Below
|
35.9
|
|
17
|
213539_at
|
CD3D antigen, delta polypeptide (TiT3 complex)
|
CD3D
|
11q23
|
NM_000732.1
|
Hs.95327
|
100.0
|
Above
|
37.0
|
|
18
|
214049_x_at
|
CD7 antigen (p41)
|
CD7
|
17q25.2-q25.3
|
AI829961
|
Hs.36972
|
100.0
|
Above
|
327.3
|
|
19
|
214551_s_at
|
CD7 antigen (p41)
|
CD7
|
17q25.2-q25.3
|
NM_006137.2
|
Hs.36972
|
100.0
|
Above
|
241.8
|
|
20
|
217147_s_at
|
T-cell receptor interacting molecule
|
TRIM
|
3q13
|
AJ240085.1
|
Hs.138701
|
100.0
|
Above
|
43.6
|
|
21
|
217478_s_at
|
MHC,
class IIa, HLA-DMA
|
HLA-DMA
|
|
X76775
|
|
100.0
|
Below
|
14.1
|
|
22
|
221969_at
|
paired box gene 5 (B-cell lineage specific activator
protein)
|
PAX5
|
9p13
|
BF510692
|
Hs.22030
|
100.0
|
Below
|
3922.0
|
|
23
|
227646_at
|
early B-cell factor
|
EBF
|
5q34
|
BG435302
|
Hs.32425
|
100.0
|
Below
|
79.2
|
|
24
|
229487_at
|
Homo sapiens cDNA FLJ39389
|
|
|
W73890
|
Hs.120785
|
100.0
|
Below
|
7685.7
|
|
25
|
229838_at
|
Homo sapiens cDNA FLJ39156
|
|
|
AI377271
|
Hs.376140
|
100.0
|
Above
|
13.4
|
|
26
|
232204_at
|
early B-cell factor
|
EBF
|
5q34
|
AF208502.1
|
Hs.32425
|
100.0
|
Below
|
7112.4
|
|
27
|
266_s_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
L33930
|
Hs.286124
|
91.3
|
Below
|
135.5
|
|
28
|
39318_at
|
T-cell leukemia/lymphoma 1A
|
TCL1A
|
14q32.1
|
X82240
|
Hs.2484
|
91.3
|
Below
|
18114.7
|
|
29
|
203965_at
|
ubiquitin specific protease 20
|
USP20
|
9q34.12-q34.13
|
NM_006676.1
|
Hs.5452
|
91.3
|
Above
|
9.6
|
|
30
|
204891_s_at
|
lymphocyte-specific protein tyrosine kinase
|
LCK
|
1p34.3
|
NM_005356.1
|
Hs.1765
|
91.3
|
Above
|
14.3
|
|
31
|
205255_x_at
|
transcription factor 7 (T-cell specific, HMG-box)
|
TCF7
|
5q31.1
|
NM_003202.1
|
Hs.169294
|
91.3
|
Above
|
8.5
|
|
32
|
207655_s_at
|
B-cell linker
|
BLNK
|
10q23.2-q23.33
|
NM_013314.1
|
Hs.167746
|
91.3
|
Below
|
133.1
|
|
33
|
209771_x_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
AA761181
|
Hs.286124
|
91.3
|
Below
|
51.5
|
|
34
|
211796_s_at
|
T cell receptor beta locus
|
TRB
|
7q34
|
AF043179.1
|
Hs.303157
|
91.3
|
Above
|
21.5
|
|
35
|
213792_s_at
|
insulin receptor
|
INSR
|
19p13.3-p13.2
|
AA485908
|
Hs.89695
|
91.3
|
Below
|
8.6
|
|
36
|
215193_x_at
|
major histocompatibility complex, class II, DR beta
3
|
HLA-DRB3
|
6p21.3
|
AJ297586.1
|
Hs.308026
|
91.3
|
Below
|
16.7
|
|
37
|
216379_x_at
|
KIAA1919 protein
|
KIAA1919
|
6q22.1
|
AK000168.1
|
Hs.381004
|
91.3
|
Below
|
56.0
|
|
38
|
219191_s_at
|
bridging integrator 2
|
BIN2
|
12q13
|
NM_016293.1
|
Hs.14770
|
91.3
|
Above
|
264.1
|
|
39
|
219563_at
|
hypothetical protein FLJ21276
|
FLJ21276
|
14q32.2
|
NM_024633.1
|
Hs.41502
|
91.3
|
Below
|
5.8
|
|
40
|
219724_s_at
|
KIAA0748 gene product
|
KIAA0748
|
12q12
|
NM_014796.1
|
Hs.33187
|
91.3
|
Above
|
11.4
|
|
41
|
221750_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
(soluble)
|
HMGCS1
|
5p14-p13
|
BG035985
|
Hs.77910
|
91.3
|
Above
|
3.5
|
|
42
|
226157_at
|
Homo sapiens cDNA FLJ39131
|
|
|
AI569747
|
Hs.379018
|
91.3
|
Above
|
4.6
|
|
43
|
226496_at
|
hypothetical protein FLJ22611
|
FLJ22611
|
9p11.1
|
BG291039
|
Hs.27774
|
91.3
|
Below
|
7.7
|
|
44
|
204214_s_at
|
RAB32, member RAS oncogene family
|
RAB32
|
6q24.3
|
NM_006834.1
|
Hs.32217
|
90.6
|
Above
|
137.0
|
|
45
|
204777_s_at
|
mal, T-cell differentiation protein
|
MAL
|
2cen-q13
|
NM_002371.2
|
Hs.80395
|
90.6
|
Above
|
95.2
|
|
46
|
204890_s_at
|
lymphocyte-specific protein tyrosine kinase
|
LCK
|
1p34.3
|
U07236.1
|
Hs.1765
|
90.6
|
Above
|
19.4
|
|
47
|
205049_s_at
|
CD79A antigen (immunoglobulin-associated alpha)
|
CD79A
|
19q13.2
|
NM_001783.1
|
Hs.79630
|
90.6
|
Below
|
11.6
|
|
48
|
205254_x_at
|
transcription factor 7 (T-cell specific, HMG-box)
|
TCF7
|
5q31.1
|
AW027359
|
Hs.169294
|
90.6
|
Above
|
377.1
|
|
49
|
205504_at
|
Bruton agammaglobulinemia tyrosine kinase
|
BTK
|
Xq21.33-q22
|
NM_000061.1
|
Hs.159494
|
90.6
|
Below
|
7.3
|
|
50
|
210915_x_at
|
T cell receptor beta locus
|
TRB
|
7q34
|
M15564.1
|
Hs.303157
|
90.6
|
Above
|
16.2
|
|
51
|
211211_x_at
|
SH2 domain protein 1A, Duncan's disease (lymphoproliferative
syndrome)
|
SH2D1A
|
Xq25-q26
|
AF100542.1
|
Hs.151544
|
90.6
|
Above
|
2103.7
|
|
52
|
213830_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
AW007751
|
Hs.2014
|
90.6
|
Above
|
7379.7
|
|
53
|
216191_s_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
X72501.1
|
Hs.2014
|
90.6
|
Above
|
253.1
|
|
54
|
217143_s_at
|
T cell receptor delta locus
|
TRD
|
14q11.2
|
X06557.1
|
Hs.2014
|
90.6
|
Above
|
150.1
|
|
55
|
219528_s_at
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
BCL11B
|
14q32.31-q32.32
|
NM_022898.1
|
Hs.57987
|
90.6
|
Above
|
11.9
|
|
56
|
220418_at
|
ubiquitin associated and SH3 domain containing,
A
|
UBASH3A
|
21q22.3
|
NM_018961.1
|
Hs.183924
|
90.6
|
Above
|
766.4
|
|
57
|
222895_s_at
|
B-cell CLL/lymphoma 11B (zinc finger protein)
|
BCL11B
|
14q32.31-q32.32
|
AA918317
|
Hs.57987
|
90.6
|
Above
|
12.1
|
|
58
|
223553_s_at
|
hypothetical protein FLJ22570
|
FLJ22570
|
5q35.3
|
BC004564.1
|
Hs.122559
|
90.6
|
Below
|
7.0
|
|
59
|
225090_at
|
HRD1 protein
|
HRD1
|
11q12
|
AA844682
|
Hs.334819
|
90.6
|
Below
|
3.8
|
|
60
|
226459_at
|
Homo sapiens gastric cancer-related protein GCYS-20
(gcys-20) mRNA, complete cds
|
|
|
AW575754
|
Hs.86437
|
90.6
|
Below
|
11.9
|
|
61
|
228314_at
|
Homo sapiens cDNA FLJ37485
|
|
|
BE877357
|
Hs.24181
|
90.6
|
Below
|
5.1
|
|
62
|
201384_s_at
|
membrane component, chromosome 17, surface marker
2 (ovarian carcinoma antigen CA125)
|
M17S2
|
17q21.1
|
NM_005899.1
|
Hs.277721
|
83.8
|
Above
|
3.3
|
|
63
|
202540_s_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
|
HMGCR
|
5q13.3-q14
|
NM_000859.1
|
Hs.11899
|
83.8
|
Above
|
4.6
|
|
64
|
203198_at
|
cyclin-dependent kinase 9 (CDC2-related kinase)
|
CDK9
|
9q34.1
|
NM_001261.1
|
Hs.150423
|
83.8
|
Below
|
5.2
|
|
65
|
203932_at
|
major histocompatibility complex, class II, DM beta
|
HLA-DMB
|
6p21.3
|
NM_002118.1
|
Hs.1162
|
83.8
|
Below
|
8.2
|
|
66
|
204613_at
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
PLCG2
|
16q24.1
|
NM_002661.1
|
Hs.75648
|
83.8
|
Below
|
4.0
|
|
67
|
205267_at
|
POU domain, class 2, associating factor 1
|
POU2AF1
|
11q23.1
|
NM_006235.1
|
Hs.2407
|
83.8
|
Below
|
11.7
|
|
68
|
208650_s_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
BG327863
|
Hs.286124
|
83.8
|
Below
|
110.8
|
|
69
|
208651_x_at
|
CD24 antigen (small cell lung carcinoma cluster
4 antigen)
|
CD24
|
6q21
|
M58664.1
|
Hs.286124
|
83.8
|
Below
|
49.3
|
|
70
|
209995_s_at
|
T-cell leukemia/lymphoma 1A
|
TCL1A
|
14q32.1
|
BC003574.1
|
Hs.2484
|
83.8
|
Below
|
20166.2
|
|
71
|
210038_at
|
protein kinase C, theta
|
PRKCQ
|
10p15
|
AL137145
|
Hs.211593
|
83.8
|
Above
|
12.7
|
|
72
|
211126_s_at
|
cysteine and glycine-rich protein 2
|
CSRP2
|
12q21.1
|
U46006.1
|
Hs.10526
|
83.8
|
Below
|
16.8
|
|
73
|
220068_at
|
pre-B lymphocyte gene 3
|
VPREB3
|
22q11.23
|
NM_013378.1
|
Hs.136713
|
83.8
|
Below
|
6559.8
|
|
74
|
226245_at
|
Homo sapiens mRNA; cDNA DKFZp451C132
|
|
|
U55984
|
Hs.356531
|
83.8
|
Above
|
9.1
|
|
75
|
202615_at
|
Homo sapiens mRNA; cDNA DKFZp686D0521
|
|
|
BF222895
|
Hs.356786
|
82.2
|
Above
|
3.1
|
|
76
|
224861_at
|
Homo sapiens cDNA FLJ31057
|
|
|
BF477658
|
Hs.296261
|
82.2
|
Above
|
3.5
|
|
77
|
201194_at
|
selenoprotein W, 1
|
SEPW1
|
19q13.3
|
NM_003009.1
|
Hs.14231
|
82.0
|
Above
|
4.0
|
|
78
|
201349_at
|
solute carrier family 9 (sodium/hydrogen exchanger),
isoform 3 regulatory factor 1
|
SLC9A3R1
|
17q25.2
|
NM_004252.1
|
Hs.184276
|
82.0
|
Above
|
2.7
|
|
79
|
202539_s_at
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
|
HMGCR
|
5q13.3-q14
|
AL518627
|
Hs.11899
|
82.0
|
Above
|
3.5
|
